53 related articles for article (PubMed ID: 2103506)
1. Implications of erbB-2 overexpression for basic science and clinical medicine.
King CR; Kraus MH; DiFiore PP; Paik S; Kasprzyk PG
Semin Cancer Biol; 1990 Oct; 1(5):329-37. PubMed ID: 2103506
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases.
Lacroix H; Iglehart JD; Skinner MA; Kraus MH
Oncogene; 1989 Feb; 4(2):145-51. PubMed ID: 2564657
[TBL] [Abstract][Full Text] [Related]
3. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers.
Freeman MR; Washecka R; Chung LW
Cancer Res; 1989 Nov; 49(22):6221-5. PubMed ID: 2572319
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
7. Regulation of epidermal growth factor receptor expression and activation: a brief review.
Haley JD
Symp Soc Exp Biol; 1990; 44():21-37. PubMed ID: 2130514
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-erbB-2 in human esophageal carcinoma cells: overexpression correlated with gene amplification or with GATA-3 transcription factor expression.
Shiga K; Shiga C; Sasano H; Miyazaki S; Yamamoto T; Yamamoto M; Hayashi N; Nishihira T; Mori S
Anticancer Res; 1993; 13(5A):1293-301. PubMed ID: 7902061
[TBL] [Abstract][Full Text] [Related]
10. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
Willmore-Payne C; Holden JA; Layfield LJ
Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
[TBL] [Abstract][Full Text] [Related]
12. Interaction of the neu/p185 and EGF receptor tyrosine kinases: implications for cellular transformation and tumor therapy.
Dougall WC; Qian X; Greene MI
J Cell Biochem; 1993 Sep; 53(1):61-73. PubMed ID: 7901229
[TBL] [Abstract][Full Text] [Related]
13. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
Iglehart JD; Kraus MH; Langton BC; Huper G; Kerns BJ; Marks JR
Cancer Res; 1990 Oct; 50(20):6701-7. PubMed ID: 2208136
[TBL] [Abstract][Full Text] [Related]
14. Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.
Robertson KW; Reeves JR; Smith G; Keith WN; Ozanne BW; Cooke TG; Stanton PD
Cancer Res; 1996 Aug; 56(16):3823-30. PubMed ID: 8706030
[TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
Hynes NE
Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
[TBL] [Abstract][Full Text] [Related]
16. Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.
Kimura M; Tsuda H; Morita D; Shinto E; Tanimoto T; Ichikura T; Mochizuki H; Matsubara O
Jpn J Clin Oncol; 2005 Jun; 35(6):324-31. PubMed ID: 15928192
[TBL] [Abstract][Full Text] [Related]
17. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
[TBL] [Abstract][Full Text] [Related]
18. EGF- and cell-cycle-regulated STAG1/PMEPA1/ERG1.2 belongs to a conserved gene family and is overexpressed and amplified in breast and ovarian cancer.
Giannini G; Ambrosini MI; Di Marcotullio L; Cerignoli F; Zani M; MacKay AR; Screpanti I; Frati L; Gulino A
Mol Carcinog; 2003 Dec; 38(4):188-200. PubMed ID: 14639658
[TBL] [Abstract][Full Text] [Related]
19. Modulation of pro-epidermal growth factor, pro-transforming growth factor alpha and epidermal growth factor receptor gene expression in human renal carcinomas.
Petrides PE; Bock S; Bovens J; Hofmann R; Jakse G
Cancer Res; 1990 Jul; 50(13):3934-9. PubMed ID: 2354442
[TBL] [Abstract][Full Text] [Related]
20. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
